Migraine Prophylaxis

Migraine Prophylaxis is a therapeutic strategy within pediatric neurologic pharmacotherapy that involves the sustained administration of pharmacologic agents to reduce the frequency, severity, and duration of migraine episodes in children, distinguishing it from acute migraine treatments by its preventive orientation and long-term application.

1.3K

Publications

81.1K

Citations

4.6K

Authors

1.6K

Institutions

Publications per year

2017–2026

317

Variants

Migraine Preventive Therapy

Authors

4.6K

  1. SD
    Stephen D. Silberstein

    Thomas Jefferson University, United States

    33 publications · 6.9K citations

    27

    h-index

  2. DW
    David W. Dodick

    Mayo Clinic in Arizona, United States

    32 publications · 4.9K citations

    26

    h-index

  3. RB
    Richard B. Lipton

    Albert Einstein College of Medicine, United States

    27 publications · 4.6K citations

    25

    h-index

  4. UR
    Uwe Reuter

    Charité - Universitätsmedizin Berlin, Germany

    22 publications · 2.6K citations

    20

    h-index

  5. PJ
    Peter J. Goadsby

    King's College London, United Kingdom

    18 publications · 2.4K citations

    16

    h-index

1–5 of 4.6K

Venues

  1. Cephalalgia

    182 publications · 18.8K citations

    68

    h-index

  2. Headache The Journal of Head and Face Pain

    239 publications · 15.8K citations

    66

    h-index

  3. The Journal of Headache and Pain

    64 publications · 3.7K citations

    35

    h-index

  4. PubMed

    Repository · 110 publications · 3.8K citations

    32

    h-index

  5. Acta Neurologica Scandinavica

    42 publications · 1.8K citations

    25

    h-index

1–5